Searched for
WEIGHT LOSS MARKET
Why is market rising? Sensex jumps 1,000 points in 2 days, Nifty crosses 23,400. 3 key factors behind the surgeIndian stock markets surged for a second consecutive session, with Sensex and Nifty crossing significant milestones. This resilience occurr...- Zepto IPO: Founders Aadit Palicha, Kaivalya Vohra skip OFS as Nexus Ventures leads share saleZepto’s founders, Aadit Palicha and Kaivalya Vohra, will retain their stakes and not participate in the Rs 9,500 crore IPO’s offer-for-sale...
- Quote of the day from investing legend Howard Marks: 'You have to be prepared for when things go against you. You have to survive on the bad days' - Life and investing lessons from Mastering the Market Cycle authorHoward Marks, a renowned investor, stresses survival over maximum returns. In one of his famous quotes, he advises investors to build resil...
- Kospi surges 5% after 15% rout in 3 sessions. What’s fuelling 2026’s top market?South Korean technology stocks rebounded sharply on Tuesday as investors returned to AI-linked shares after a steep three-day selloff that ...
- US stocks: S&P 500, Nasdaq end up as tech, chipmakers reboundU.S. stocks largely rose Monday, with the Nasdaq and chipmakers leading the gains as investors sought bargains after Friday's selloff. Reli...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- US stocks | Alphabet taps Intel to make three million in-house chips: ReportNvidia has not placed an order with Intel yet, but has been evaluating whether the company's technology can be used to make a processor tha...
- US stocks today: US market gains as semiconductor stocks rebound, Middle East tensions easeMajor Wall Street indexes saw a strong rebound. This recovery was driven by gains in chip stocks. Signs of de-escalation in Middle East ten...
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
- US stocks today: S&P 500, Nasdaq slides as chip stocks fall, jobs data fuels hawkish Fed fearsMarkets saw a dip on Friday. Chipmaker stocks weakened after a strong rally. A better-than-expected jobs report fueled expectations of a US...
- US Stock Market today: Nasdaq, S&P 500 set for low opening, Dow Jones to rise. Nvidia stocks, Intel, Micron, AMD, Broadcom shares under spotlightS&P 500, if remains low, would register its first weekly decline since April. The tech-heavy Nasdaq was also set to end the week slightly ...
- S&P 500 setback for Elon Musk owned SpaceX as swift entry for world's biggest-ever IPO into US Stock Market benchmark index ruled out, claim reportsSpaceX posted a net loss of $4.94 billion in 2025, even as revenue rose 33 per cent to $18.67 billion.
- Those willing to look beyond the fog of war: 5 large-caps from different sectors with upside potential of up to 28%The news mix could not be more confusing. On the one hand, the US House voted to halt Trump’s Iran war, and Israel and Lebanon again agreed...
- Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
- ETMarkets PMS Talk | We stayed fully invested through elections, tariffs and war fears — and outperformed: Manish Gupta & Viraj Mahadevia of MoneyGrow PMSMoneyGrow PMS has navigated market volatility by focusing on businesses with consistent earnings growth. The fund house identifies opportun...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- RBI reviews expected credit loss rules amid concerns over impact on SME credit costsThe Reserve Bank of India is taking a closer look at its credit loss regulations, which may result in higher borrowing costs for small and ...
- Explained: NSE extends F&O trading by 10 minutes. What changes for traders?The NSE will introduce the Closing Auction Session (CAS) framework in the equity derivatives segment from August 3, 2026. While market clos...
- NSE extends equity F&O segment timings till 3:40 pm from AugustThe National Stock Exchange (NSE) will extend equity derivatives trading hours by 10 minutes, with the market now closing at 3:40 pm, effec...
- MSCI index rejig, US-Iran deal worries spook Dalal StreetIndian stock markets experienced a significant drop on Friday, with major indices closing lower. This decline was largely driven by outflow...
Load More
